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The immune system takes its cues from antigen-
presenting cells (APCs) to either go on the offensive 
against a foreign enemy or to stand down and tolerate 
a harmless threat. Ehirchiou et al. (page 1519) now 
report a new mechanism by which APCs power down the 
immune system: an APC surface receptor suppresses the 
development of overzealous T helper (Th)-17 cells.
According to dogma, APCs that have only few 
costimulatory receptors dampen immunity. These APCs 
can’t give T cells the stimulatory boost they need to become 
offensive. But some APCs with lots of costimulatory 
receptors can somehow still keep T cells in low gear.
One APC receptor that might direct this alternative 
pathway, the authors hypothesized, is CD11b. 
Mice need this integrin to remove neutrophils and 
macrophages from infection sites and subdue 
inflammation. CD11b deficiency also worsens 
autoimmunity, suggesting that the receptor might 
enable the immune system to tolerate certain antigens.
The authors studied the effect of CD11b on 
tolerance by feeding normal and CD11b-deficient mice 
low doses of ovalbumin (OVA) for a week and then 
challenging them with high doses of 
this antigen. The CD11b-deficient mice 
failed this tolerance test and generated 
high levels of OVA-specific T cells. 
Tolerance was restored, however, when 
these mice were supplied with APCs 
from normal mice.
The CD11b-deficient mice had high 
levels of two cytokines, IL-6 and IL-23, 
which support the growth of Th17 cells, 
a T cell subset that is associated with 
allergies and autoimmunity. The 
mutant mice had almost three times 
the normal numbers of Th17 cells, 
suggesting that CD11b suppresses the 
growth of this dangerous T cell subset 
and thereby establishes tolerance.
The authors are now investigating 
whether CD11b signaling directly blocks IL-6/IL-23 
production and whether a particular APC subset 
requires CD11b expression to prevent the development 
of Th17 cells. 
TH17 cells thrive and react 
to the OVA antigen in mice 
lacking CD11b.
AID overwhelms Polβ 
in class-switching B cells
The machinery that repairs spontaneous DNA mutations fails when the 
mutations are purposely induced by an enzyme in activated B cells. Wu 
and Stavnezer (page 1677) now find that the enzyme wins because it 
induces too much damage for repair proteins to keep up with.
The spontaneous mutation of cytosine bases to uracils is corrected 
by a process that removes the wrong bases, cuts the DNA at the empty 
spots, and reinserts the correct bases. This normally efficient process 
fails in B cells that are switching from producing IgM to making other 
classes of antibodies. In these cells, cytosines are converted to uracils 
by the enzyme activation-induced deaminase (AID). The mutated DNA is cut normally, but the ends 
then recombine to produce new types of antibodies. Recombination thus occurs at the expense of repair.
The repair failure is blamed on DNA polymerase β (Polβ), whose job is to add back the correct 
nucleotides. Scientists have proposed that B cells undergoing class switching have too little Polβ or that 
the damaged DNA sites are not accessible to the enzyme.
But Wu and Stavnezer now show that Polβ is probably as productive in B cells as it is in other cell types. 
Polymerase levels were normal, and the enzyme found its way to damaged sites. Activated B cells lacking the 
polymerase had even more mutations—and more recombination events—than usual.
The team needed a new explanation. They hypothesized that recombination happens because AID 
creates too many damaged sites for Polβ to repair. The absence of Polβ caused a noticeable increase in 
recombination only in antibody genes with relatively few AID target sequences. Recombination events 
were abundant, however, in genes with lots of AID targets whether or not Polβ was present. Thus Polβ 
repairs AID-induced lesions, but can only fix so many. 
Activated B cells need their repair machinery to protect themselves from unwanted mutations during 
antibody gene rearrangement. The authors speculate that, to switch antibody types, B cells thus have had to 
dilute the efficiency of the repair process by gaining more AID targets in antibody genes. 
DNA Polβ-deficient B cells switch more frequently when AID 
targets are sparse (IgG2a).
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